<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Melanoma Research Foundation | allison | Activity</title>
	<link>https://forum.melanoma.org/user/allison/activity/</link>
	<atom:link href="https://forum.melanoma.org/user/allison/activity/feed/" rel="self" type="application/rss+xml" />
	<description>Activity feed for allison.</description>
	<lastBuildDate>Sun, 05 Apr 2026 19:07:59 -0400</lastBuildDate>
	<generator>https://buddypress.org/?v=</generator>
	<language>en-US</language>
	<ttl>30</ttl>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>2</sy:updateFrequency>
	
						<item>
				<guid isPermaLink="false">0eff39ba8f14f74677c73a8308a09443</guid>
				<title>allison replied to the topic Join Our One-Time Patient Advisory Board on TIL Cell Therapy! in the forum General Melanoma Community</title>
				<link>https://forum.melanoma.org/forums/topic/join-our-one-time-patient-advisory-board-on-til-cell-therapy/#post-280846</link>
				<pubDate>Thu, 09 Oct 2025 10:55:57 -0400</pubDate>

									<content:encoded><![CDATA[<p> This is a great opportunity to contribute to advancements in TIL Cell Therapy. I recently read some <a href="https://bestassignmenthelpau.com/reviews/" rel="nofollow ugc">Best Assignment Help AU reviews</a> , and it reminded me how valuable sharing experiences and insights can be. Looking forward to seeing the impact of this advisory board.</p>
]]></content:encoded>
				
				
							</item>
					<item>
				<guid isPermaLink="false">d77655d596e00d0160aa6ae02fb455e5</guid>
				<title>allison became a registered member</title>
				<link>https://forum.melanoma.org/activity/p/132810/</link>
				<pubDate>Thu, 09 Oct 2025 10:51:52 -0400</pubDate>

				
									<slash:comments>0</slash:comments>
				
							</item>
		
	</channel>
</rss>